These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34872936)

  • 1. Targeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes.
    Panzer JK; Caicedo A
    Diabetes; 2021 Dec; 70(12):2721-2732. PubMed ID: 34872936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring glutamate receptor signaling in pancreatic alpha cells rescues glucagon responses in type 1 diabetes.
    Panzer JK; Tamayo A; Caicedo A
    Cell Rep; 2022 Dec; 41(11):111792. PubMed ID: 36516761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.
    Guyton J; Jeon M; Brooks A
    Am J Health Syst Pharm; 2019 Oct; 76(21):1739-1748. PubMed ID: 31612934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vildagliptin reduces glucagon during hyperglycemia and sustains glucagon counterregulation during hypoglycemia in type 1 diabetes.
    Farngren J; Persson M; Schweizer A; Foley JE; Ahrén B
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3799-806. PubMed ID: 22855332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.
    Cryer PE; Gerich JE
    N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits.
    Powell AM; Sherwin RS; Shulman GI
    J Clin Invest; 1993 Dec; 92(6):2667-74. PubMed ID: 8254023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.
    Karimian N; Qin T; Liang T; Osundiji M; Huang Y; Teich T; Riddell MC; Cattral MS; Coy DH; Vranic M; Gaisano HY
    Diabetes; 2013 Aug; 62(8):2968-77. PubMed ID: 23630299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-impairment of autonomic and glucagon responses to insulin-induced hypoglycemia in dogs with naturally occurring insulin-dependent diabetes mellitus.
    Gilor C; Duesberg C; Elliott DA; Feldman EC; Mundinger TO; Taborsky GJ; Nelson RW; Havel PJ
    Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1074-E1083. PubMed ID: 33044845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational aspects of glucagon: current use and future prospects.
    Kaur J; Seaquist ER
    J Endocrinol; 2023 Apr; 257(1):. PubMed ID: 36727600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in blunted glucagon response to insulin-induced hypoglycemia by strict glycemic control in diabetics.
    Katsura M; Kawamori R; Yamasaki Y; Iwama N; Kubota M; Goriya Y; Kajimoto Y; Shichiri M; Kamada T
    Diabetes Res Clin Pract; 1993 May; 20(2):93-100. PubMed ID: 8375272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The science of hypoglycemia in patients with diabetes.
    Oyer DS
    Curr Diabetes Rev; 2013 May; 9(3):195-208. PubMed ID: 23506375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypoglycemia associated autonomic failure triggered by exercise in the patients with "brittle" diabetes and the strategy for prevention.
    Mao Y; Wen S; Zhou M; Zhu S; Zhou L
    Endocr J; 2019 Sep; 66(9):753-762. PubMed ID: 31406090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypoglycemia--occurrence, causes and hormonal counterregulatory mechanisms in healthy persons and in patients with IDDM].
    Mokán M
    Bratisl Lek Listy; 1995 Jun; 96(6):311-6. PubMed ID: 7552408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of the blunted glucagon response to insulin-induced hypoglycemia in diabetics].
    Katsura M
    Nihon Naibunpi Gakkai Zasshi; 1986 Nov; 62(11):1276-88. PubMed ID: 3542595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes.
    Rickels MR; DuBose SN; Toschi E; Beck RW; Verdejo AS; Wolpert H; Cummins MJ; Newswanger B; Riddell MC;
    Diabetes Care; 2018 Sep; 41(9):1909-1916. PubMed ID: 29776987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
    Matyka KA; Crowne EC; Havel PJ; Macdonald IA; Matthews D; Dunger DB
    Diabetes Care; 1999 Jul; 22(7):1144-50. PubMed ID: 10388980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemia in diabetes.
    Cryer PE; Davis SN; Shamoon H
    Diabetes Care; 2003 Jun; 26(6):1902-12. PubMed ID: 12766131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
    Cryer PE
    Endocrinology; 2012 Mar; 153(3):1039-48. PubMed ID: 22166985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes.
    Galassetti P; Tate D; Neill RA; Morrey S; Wasserman DH; Davis SN
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E16-24. PubMed ID: 14998785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.